The experience of high-flow nasal cannula in hospitalized patients with 2019 novel coronavirus-infected pneumonia in two hospitals of Chongqing, China

Annals of Intensive Care

Volumn 10, Issue 1, 2020, Pages

  Wang, Ke ^a   Zhao, Wei ^a   Li, Ji ^b   Shu, Weiwei ^c   Duan, Jun ^d  

^a THE SECOND AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b Chong Qing Public Health Medical Center   (China)

^c CHONGQING MEDICAL UNIVERSITY   (China)

^d THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Coronavirus; High flow nasal cannula; Pneumonia

Indexed keywords

OXYGEN;

ACUTE RESPIRATORY FAILURE; AGED; APACHE; ARTERIAL OXYGEN TENSION; ARTICLE; ARTIFICIAL VENTILATION; BREATHING RATE; CHINA; CORONAVIRUS DISEASE 2019; CRITICALLY ILL PATIENT; DISEASE SEVERITY; FEMALE; FRACTION OF INSPIRED OXYGEN; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NONINVASIVE VENTILATION; OBSERVATIONAL STUDY; OXYGEN CONCENTRATION; OXYGEN THERAPY; PRIORITY JOURNAL; RESPIRATORY TRACT INTUBATION; RESPIRATORY TRACT PARAMETERS; RETROSPECTIVE STUDY; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; VIRUS PNEUMONIA;

EID: 85082536012     PISSN: None     EISSN: 21105820     Source Type: Journal    
DOI: 10.1186/s13613-020-00653-z     Document Type: Article

References (21)

1. Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020. 10.1038/s41586-020-2012-7.
2. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020. 10.1016/S0140-6736(20)30183-5.
3. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020. 10.1016/S0140-6736(20)30211-7.
4. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020. 10.1001/jama.2020.1585.
5. Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020. 10.1056/NEJMoa2001316.
6. Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020. 10.1016/S0140-6736(20)30154-9.
7. Yu P, Zhu J, Zhang Z, et al. A familial cluster of infection associated with the 2019 novel coronavirus indicating potential person-to-person transmission during the incubation period. J Infect Dis. 2020. 10.1093/infdis/jiaa077.
8. Holshue ML, DeBolt C, Lindquist S, Case First, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020. 10.1056/NEJMoa2001191.
9. Kim JY, Choe PG, Oh Y, et al. The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China: implication for infection prevention and control measures. J Korean Med Sci. 2020;35:e61.
10. Silverstein WK, Stroud L, Cleghorn GE, et al. First imported case of 2019 novel coronavirus in Canada, presenting as mild pneumonia. Lancet. 2020. 10.1016/S0140-6736(20)30370-6.
11. Stoecklin SB, Rolland P, Silue Y, et al. First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020. Euro Surveill. 2020. 10.2807/1560-7917.ES.2020.25.6.2000094.
12. Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41:145–51.
13. Frat JP, Thille AW, Mercat A, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med. 2015;372:2185–96.
14. Branson RD, Hess DR, Chatbum RL. Respiratory care equipment. Philadelphia: J.B. Lippincott Company; 1995. p. 55–62.
15. Zhao H, Wang H, Sun F, et al. High-flow nasal cannula oxygen therapy is superior to conventional oxygen therapy but not to noninvasive mechanical ventilation on intubation rate: a systematic review and meta-analysis. Crit Care. 2017;21:184.
16. Cortegiani A, Crimi C, Noto A, et al. Effect of high-flow nasal therapy on dyspnea, comfort, and respiratory rate. Crit Care. 2019;23:201.
17. Stephan F, Berard L, Rezaiguia-Delclaux S, et al. High-flow nasal cannula therapy versus intermittent noninvasive ventilation in obese subjects after cardiothoracic surgery. Respir Care. 2017;62:1193–202.
18. Special Expert Group for Control of the Epidemic of Novel Coronavirus Pneumonia of the Chinese Preventive Medicine Association. An update on the epidemiological characteristics of novel coronavirus pneumonia COVID-19. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41:139–44.
19. Hui DS, Chow BK, Lo T, et al. Exhaled air dispersion during high-flow nasal cannula therapy versus CPAP via different masks. Eur Respir J. 2019;53:1802339.
20. Kang H, Zhao Z, Tong Z. Effect of high-flow nasal cannula oxygen therapy in immunocompromised subjects with acute respiratory failure. Respir Care. 2019. 10.4187/respcare.07205.
21. Chikata Y, Unai K, Izawa M, et al. Inspiratory tube condensation during high-flow nasal cannula therapy: a bench study. Respir Care. 2016;61:300–5.